Host cell protein


Viewing related articles

Host cell protein risk assessment- Where we are with BioPhorum cross-company collaboration and what we have learnt from an industry perspective?

May 2022 | , , , ,

A presentation on cross-company collaborative work and learnings produced from an industry perspective on host cell protein risk assessment. The presentation included a history of the HCP workstream, previous publications, planned future work and publication plans.

read more

“High-risk” host cell proteins (HCPs): A multi-company collaborative view

Sep 2021 | , , ,

This database and paper provide a comprehensive review and list of potential problematic HCPs that could impact the safety, efficacy, and quality aspects of CHO-produced biologics during their development and manufacturing. They provide a reference on the best practice and control strategy for “high-risk” HCPs” in the biopharmaceutical industry.

read more

Follow BioPhorum

Search BioPhorum

Phorums

Industry priorities